Back to Home
Skip navigation links
PROJECT INFORMATION
STATISTICS
DATA MANAGEMENT
LINKS
Back to Home site

Sign In


Skip navigation links
PROJECT INFORMATION
WORK PACKAGESExpand WORK PACKAGES
DELIVERABLES
DISSEMINATION
FINAL REPORTSExpand FINAL REPORTS
STATISTICSExpand STATISTICS
DATA MANAGEMENT
ROAD MAP INITIATIVE
PARTNERSExpand PARTNERS
WHO IS WHO
EU FUNDING
Patient Support Groups
Donor Registries
Clinical Trials Groups
General Trials Information
National BMT Registries

 Guidelines

 
This page has a list of documents, publicly available, to share our views on the analysis of (survival) data.

  • Definition and evaluation of endpoints following stem cell transplantation - Recommedation from the European Group for Blood and Marrow Transplantation - Sept 2009   Endpoints
  • Statistical modeling of complex disease histories in BMT: Guidelines for proper use and interpretation of the Cox model  guide_cox.pdf
  • EBMT guidelines (2003) M. Labopin and S. Iacobelli    StatGuidelines_oct2003.pdf  New Version available shortly!

Guidelines or tutorials  from other research groups:

  • CASCADE  (Concerted Action on SeroConversion to AIDS and Death in Europe):
              o A Practical Guide on Modeling Competing Risk Data by Giorgos Bakoyannis and Giota Touloumi on behalf of CASCADE Collaboration
  • Anthony Gichangi and Werner Vach: The analysis of competing risks data: A guided tour. November, 2005
  • FDA Guidance: The FINAL  guidance of Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics 7478fnl.pdf

 Press Releases

CLINT Project website goes live
EBMT investigates challenges
Better Late Than Never
Road Map Initiative for Clinical Research in Europe
Review of the European Clinical Trials Directive
 
Copyright © 2009 EBMT